Suppr超能文献

血小板的渗透稳定性。

Osmotic stability of blood platelets.

作者信息

Fantl P

出版信息

J Physiol. 1968 Sep;198(1):1-16. doi: 10.1113/jphysiol.1968.sp008590.

Abstract
  1. Hypotonic solutions added to human platelet-containing plasma cause a transient decrease of absorbancy of light at 610 mmu which is followed by a gradual increase of absorbancy.2. When platelets are stored for 7 hr at 4 degrees C the absorbancy changes with variations of osmolarity and their aggregation with adenosine diphosphate (ADP) remain the same. However, the reversal of absorbancy declines during storage of platelet-containing plasma.3. Platelets are not aggregated by stearate. Platelets appear to be only slightly affected by stearate concentration higher than 0.8 mM, but oleate has no effect.4. Hypertonic solutions of NaCl and urea cause increase in absorbancy of platelet-containing human plasma. Hypertonic sucrose solutions produce no more change than isotonic solutions. Hypertonic NaCl produces permanent increases in absorbancy. In human platelet-containing plasma the increased absorbancy caused by hypertonic urea is transient and declines.5. The osmotic platelet changes occur in isolated platelets as well as in platelet-containing plasma.6. The absorbancy of frozen and thawed platelet-containing plasma is not significantly altered by hypotonic solutions but the absorbancy changes caused by hypertonic solutions are similar to that of unfrozen plasma.7. The immediate absorbancy changes caused by hypo- and by hypertonic solutions are the same at 5 degrees C and 30 degrees C and are therefore probably of a physical nature. The reversal of absorbancy and aggregation of platelets by added adenosine diphosphate have Q(10) > 1 and are therefore probably of a chemical-enzymic nature.8. Divalent cations and contact activation are not required for the osmotic platelet changes and 10(-3)M-Cu(2+) and Zn(2+) do not interfere. Inhibitors of oxidative phosphorylation, electron transfer, sodium, potassium activated adenosine triphosphatases and adenosine triphosphate do not inhibit reversal of absorbancy of platelets exposed to hypotonic solutions. Cyanide, 5 x 10(-3)M, fluoride, 1.23 x 10(-2)M, iodoacetamide, 10(-2)M, are moderately effective inhibitors. At hydrogen ion concentrations above pH 8, complete inhibition occurs.9. N-ethyl-maleimide, 10(-3)M, and mercloran inhibit completely reversal of absorbancy, indicating the necessity for sulphydryl compounds.10. Intact platelets are essential for the reversal of absorbancy after hypotonic swelling. Osmotic changes by hypotonic solutions are independent of ADP aggregation of platelets.
摘要
  1. 向含人血小板的血浆中加入低渗溶液会导致610毫微米处光吸收度短暂下降,随后吸收度逐渐增加。

  2. 当血小板在4℃下储存7小时时,吸收度随渗透压变化而改变,且它们与二磷酸腺苷(ADP)的聚集情况保持不变。然而,含血小板血浆储存期间吸收度的逆转会下降。

  3. 血小板不会被硬脂酸盐聚集。血小板似乎仅受到高于0.8毫摩尔/升的硬脂酸盐浓度的轻微影响,但油酸盐没有影响。

  4. 氯化钠和尿素的高渗溶液会导致含人血小板血浆的吸收度增加。高渗蔗糖溶液产生的变化与等渗溶液相比并无更多改变。高渗氯化钠会使吸收度持续增加。在含人血小板血浆中,高渗尿素引起的吸收度增加是短暂的且会下降。

  5. 渗透压引起的血小板变化在分离的血小板以及含血小板血浆中均会发生。

  6. 冻融后的含血小板血浆的吸收度不会因低渗溶液而显著改变,但高渗溶液引起的吸收度变化与未冻融血浆相似。

  7. 低渗和高渗溶液引起的即时吸收度变化在5℃和30℃时相同,因此可能是物理性质的。加入二磷酸腺苷后血小板吸收度的逆转和聚集的Q(10)>1,因此可能是化学酶促性质的。

  8. 二价阳离子和接触激活对于渗透压引起的血小板变化并非必需,10⁻³摩尔/升的铜离子(Cu²⁺)和锌离子(Zn²⁺)不会产生干扰。氧化磷酸化、电子传递、钠钾激活的三磷酸腺苷酶和三磷酸腺苷的抑制剂不会抑制暴露于低渗溶液的血小板吸收度的逆转。5×10⁻³摩尔/升的氰化物、1.23×10⁻²摩尔/升的氟化物、10⁻²摩尔/升的碘乙酰胺是中等有效的抑制剂。在氢离子浓度高于pH 8时,会发生完全抑制。

  9. 10⁻³摩尔/升的N - 乙基马来酰亚胺和汞氯醛完全抑制吸收度的逆转,表明巯基化合物的必要性。

  10. 完整的血小板对于低渗肿胀后吸收度的逆转至关重要。低渗溶液引起的渗透压变化与血小板的ADP聚集无关。

相似文献

1
Osmotic stability of blood platelets.血小板的渗透稳定性。
J Physiol. 1968 Sep;198(1):1-16. doi: 10.1113/jphysiol.1968.sp008590.

本文引用的文献

4

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验